Healthcare provider profile · identity verified

Samuel M Edwards, M. D.

Internal Medicine · DELAND, FL · NPI 1386706000

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	307	74
Amlodipine Besylate	Amlodipine Besylate	291	81
Atorvastatin Calcium	Atorvastatin Calcium	259	65
Potassium Chloride	Potassium Chloride	231	39
Eliquis	Apixaban	219	23
Furosemide	Furosemide	191	43
Memantine Hcl	Memantine Hcl	187	19
Escitalopram Oxalate	Escitalopram Oxalate	164	37
Metoprolol Tartrate	Metoprolol Tartrate	164	37
Losartan Potassium	Losartan Potassium	153	40
Donepezil Hcl	Donepezil Hcl	147	28
Simvastatin	Simvastatin	142	34
Rosuvastatin Calcium	Rosuvastatin Calcium	141	48
Metoprolol Succinate	Metoprolol Succinate	129	23
Lisinopril	Lisinopril	125	30
Allopurinol	Allopurinol	121	19
Montelukast Sodium	Montelukast Sodium	113	17
Omeprazole	Omeprazole	92	33
Gabapentin	Gabapentin	89	23
Clopidogrel	Clopidogrel Bisulfate	84	23
Pantoprazole Sodium	Pantoprazole Sodium	84	25
Tamsulosin Hcl	Tamsulosin Hcl	82	15
Metformin Hcl	Metformin Hcl	78	20
Gemtesa	Vibegron	72	suppressed
Levetiracetam	Levetiracetam	65	suppressed
Pravastatin Sodium	Pravastatin Sodium	64	13
Trazodone Hcl	Trazodone Hcl	63	20
Azithromycin	Azithromycin	57	52
Meloxicam	Meloxicam	57	22
Hydrochlorothiazide	Hydrochlorothiazide	54	15
Spironolactone	Spironolactone	48	suppressed
Xarelto	Rivaroxaban	48	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	37
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	45	15
Latanoprost	Latanoprost	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Digoxin	Digoxin	42	suppressed
Levofloxacin	Levofloxacin	42	35
Bumetanide	Bumetanide	36	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Lactulose	Lactulose	34	suppressed
Myrbetriq	Mirabegron	32	suppressed
Nystatin	Nystatin	32	15
Albuterol Sulfate Hfa	Albuterol Sulfate	31	19
Benazepril Hcl	Benazepril Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Metolazone	Metolazone	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	15
Telmisartan	Telmisartan	29	suppressed
Baclofen	Baclofen	27	suppressed
Carvedilol	Carvedilol	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	23
Finasteride	Finasteride	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Nyamyc	Nystatin	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	12
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	12
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Valsartan	Valsartan	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Famotidine	Famotidine	21	suppressed
Prednisone	Prednisone	21	17
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	19	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Methylprednisolone	Methylprednisolone	18	18
Doxepin Hcl	Doxepin Hcl	17	suppressed
Linzess	Linaclotide	17	suppressed
Nystop	Nystatin	17	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	12
Alprazolam	Alprazolam	15	11
Azelastine Hcl	Azelastine Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	11
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	14
Lidocaine Hcl	Lidocaine Hcl/Pf	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Jardiance	Empagliflozin	12	suppressed
Primidone	Primidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Atenolol	Atenolol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error